China moves to streamline medtech regulatory process

05/20/2013 | (Boston)

The China Food and Drug Administration has adopted measures to enhance its process for medical device classification, including setting up a system to allow firms to submit their product classification requests online. The agency also hopes to streamline the regulatory pathway for innovative devices in China by developing a special approval program for such products.

View Full Article in: (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID